IE44690L - Compositions containing polyvinylbenzenesulphonic acids. - Google Patents

Compositions containing polyvinylbenzenesulphonic acids.

Info

Publication number
IE44690L
IE44690L IE770111A IE11177A IE44690L IE 44690 L IE44690 L IE 44690L IE 770111 A IE770111 A IE 770111A IE 11177 A IE11177 A IE 11177A IE 44690 L IE44690 L IE 44690L
Authority
IE
Ireland
Prior art keywords
compositions containing
substituted
acids
polyvinylbenzenesulphonic
copolymerization
Prior art date
Application number
IE770111A
Other versions
IE44690B1 (en
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Publication of IE44690L publication Critical patent/IE44690L/en
Publication of IE44690B1 publication Critical patent/IE44690B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F12/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F12/02—Monomers containing only one unsaturated aliphatic radical
    • C08F12/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F12/14—Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing heteroatoms
    • C08F12/30—Sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/10—Copolymer characterised by the proportions of the comonomers expressed as molar percentages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Water-soluble polymers having a molecular weight in the range of 100,000 to 2,000,000 including homopolymers and copolymers of vinylbenzenesulfonic acids and salts thereof wherein the benzene ring may be substituted by various radicals, compositions containing said products and methods useful in the treatment of ulcers are disclosed. The products are prepared by polymerization or copolymerization of vinylbenzene or substituted vinylbenzene followed by sulfonation or alternatively by the polymerization or copolymerization of substituted or unsubstituted vinylbenzenesulfonic acid salts. [CA1114997A]
IE111/77A 1976-02-04 1977-01-20 Pharmaceutical compositions containing polyvinylbenzenosulfonic acids IE44690B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65520076A 1976-02-04 1976-02-04
US75269376A 1976-12-20 1976-12-20

Publications (2)

Publication Number Publication Date
IE44690L true IE44690L (en) 1977-08-04
IE44690B1 IE44690B1 (en) 1982-02-24

Family

ID=27096927

Family Applications (1)

Application Number Title Priority Date Filing Date
IE111/77A IE44690B1 (en) 1976-02-04 1977-01-20 Pharmaceutical compositions containing polyvinylbenzenosulfonic acids

Country Status (10)

Country Link
JP (1) JPS5296748A (en)
AU (1) AU514389B2 (en)
CA (1) CA1114997A (en)
DE (1) DE2704329A1 (en)
DK (1) DK44777A (en)
FR (1) FR2340330A1 (en)
GB (1) GB1576016A (en)
IE (1) IE44690B1 (en)
NL (1) NL7701168A (en)
SE (2) SE430070B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395392A (en) * 1980-06-24 1983-07-26 Adria Laboratories Inc. Method for treating kidney stones
US4375461A (en) * 1980-07-25 1983-03-01 Johnson & Johnson Products, Inc. Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers
US4432967A (en) * 1982-06-25 1984-02-21 National Starch And Chemical Corp. Contraceptive composition
DE69317818T2 (en) * 1992-07-13 1998-08-06 Tosoh Corp Process for the preparation of tertiary alcohols
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
EP1508578A4 (en) * 2002-05-24 2006-01-04 Sony Corp ION CONDUCTIVE POLYMER, SOLID POLYELECTROLYTE, AND BATTERY CONTAINING THE SAME
BR0312884A (en) * 2002-07-22 2005-06-14 Genzyme Corp Polystyrene sulfonate copolymer, method of preparation and pharmaceutical composition comprising the same, method for treating, inhibiting the onset and recurrence of diarrhea, treatment regimen, mixing and pharmaceutical composition
AU2003903547A0 (en) * 2003-07-10 2003-07-24 Neoferma Australia Pty Ltd Structures and methods of waterproofing same
JP6271378B2 (en) * 2014-09-05 2018-01-31 信越化学工業株式会社 Polymer compound for conductive polymer and method for producing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310481A (en) * 1962-09-10 1967-03-21 Dow Chemical Co Removal of residual monomeric sulfonates from polymerizates thereof
JPS4936644A (en) * 1972-08-15 1974-04-05

Also Published As

Publication number Publication date
JPS5296748A (en) 1977-08-13
SE426835B (en) 1983-02-14
SE7700670L (en) 1977-08-05
FR2340330B1 (en) 1981-05-29
CA1114997A (en) 1981-12-22
AU2193477A (en) 1978-08-10
NL7701168A (en) 1977-08-08
FR2340330A1 (en) 1977-09-02
DE2704329A1 (en) 1977-08-18
GB1576016A (en) 1980-10-01
SE8106138L (en) 1981-10-16
AU514389B2 (en) 1981-02-05
IE44690B1 (en) 1982-02-24
SE430070B (en) 1983-10-17
DK44777A (en) 1977-08-05

Similar Documents

Publication Publication Date Title
AU511085B2 (en) Water-soluble dispersions of high molecular weight water-soluble polymers
IE44690L (en) Compositions containing polyvinylbenzenesulphonic acids.
FI871902L (en) FOERFARANDE FOER POLYMERIZATION AV FLUORERADE MONOMERER I VATTENDISPERSION.
FI871900L (en) FOERFARANDE FOER POLYMERIZATION AV FLUORERADE MONOMERER I VATTENDISPERSION.
AU6314286A (en) Olefinic benzyocyclobutene and polymers and processes for the preparation thereof
JPS51148788A (en) A process for preparing hydrophilic polymers
AU514518B2 (en) Controlling molecular weight distribution of latex polymers
DE3766792D1 (en) PRODUCTION OF POLY (N-VINYLAMIDES) WITH A HIGH MOLECULAR WEIGHT AND POLYVINYLAMINE BY POLYMERIZATION IN REVERSE EMULSION.
EP0199316A3 (en) Chain-transfer agents for emulsion polymerization and polymer products produced therewith
IE790950L (en) Pyridopyrimidones plastics web with a three-dimension microstructure
IE43093L (en) Radical polymerisation of ethylene
IE810629L (en) Process
CA995846A (en) Procedure for the production of polymers and copolymers of isobutylene at a high molecular weight
EP0220017A3 (en) Polymer compositions with improved flow characteristics
CA1025596A (en) High molecular weight, water-soluble polymers
JPS531278A (en) Preparation of conjugated diene polymers
EP0365340A3 (en) Copolymers of 4-hydroxystyrene and alkyl substituted-4-hydroxystyrene
JPS5438389A (en) Preparation of highly crystalline polyolefin
JPS536393A (en) Preparation of water-soluble cationic polymers
AU1350776A (en) Melt polymerization process for increasing the molecular weight of poly(1, 4-butylene terephthalate
JPS51129475A (en) A process for polymerizing monomers
CA1011497A (en) Polymerization of 1,4-halosubstituted-2,3-epoxybutanes and finely divided crystalline polymer products
JPS5271586A (en) Production of high molecular weight cationic polymer
JPS5278985A (en) Polymerization of vinyl chloride polymers
FR2341604A1 (en) PROCESS FOR POLYMERIZATION OF MONOMERS IN DISPERSION, IN THE PRESENCE OF A COPOLYMER DISPERSION